Total Payments
$1,210
2024 Payments
$374.22
Companies
21
Transactions
60
Medicare Patients
918
Medicare Billing
$42,260
Payment Breakdown by Category
Food & Beverage$1,105 (91.4%)
Education$104.61 (8.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,105 | 58 | 91.4% |
| Education | $104.61 | 2 | 8.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $227.92 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $149.46 | 8 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $105.72 | 6 | $0 (2024) |
| Astellas Pharma US Inc | $102.03 | 2 | $0 (2023) |
| PFIZER INC. | $73.04 | 4 | $0 (2024) |
| Lilly USA, LLC | $68.79 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $61.16 | 3 | $0 (2024) |
| Lundbeck LLC | $57.39 | 3 | $0 (2023) |
| Alnylam Pharmaceuticals Inc. | $51.38 | 3 | $0 (2024) |
| Novo Nordisk Inc | $42.17 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $374.22 | 18 | ABBVIE INC. ($71.29) |
| 2023 | $451.95 | 20 | Astellas Pharma US Inc ($102.03) |
| 2022 | $195.19 | 11 | AstraZeneca Pharmaceuticals LP ($56.67) |
| 2021 | $188.41 | 11 | Lilly USA, LLC ($52.51) |
All Payment Transactions
60 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: UROLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: Endocrinology | ||||||
| 10/01/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $27.14 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Respiratory | ||||||
| 09/03/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO, AREXVY | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: VACCINES | ||||||
| 08/20/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.24 | General |
| Category: Cardiovascular | ||||||
| 08/13/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $29.98 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Obesity | ||||||
| 06/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Gastroenterology | ||||||
| 06/12/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $27.39 | General |
| Category: Respiratory | ||||||
| 04/25/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: Gastroenterology | ||||||
| 03/26/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Genetic Disease | ||||||
| 03/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: Gastroenterology | ||||||
| 03/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $26.96 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Diabetes | ||||||
| 01/30/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: VACCINES | ||||||
| 12/19/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.93 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Gastroenterology | ||||||
| 11/20/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.43 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Obesity | ||||||
| 09/12/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 298 | 342 | $59,935 | $11,521 |
| 2022 | 9 | 362 | 417 | $66,990 | $18,752 |
| 2021 | 6 | 258 | 301 | $48,850 | $11,987 |
Total Patients
918
Total Services
1,060
Medicare Billing
$42,260
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 83 | 110 | $27,500 | $4,012 | 14.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 101 | $17,675 | $4,011 | 22.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 33 | 33 | $6,675 | $1,639 | 24.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 17 | 18 | $1,800 | $666.37 | 37.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 14 | $4,200 | $370.08 | 8.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 12 | 12 | $360.00 | $352.80 | 98.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 17 | 19 | $475.00 | $180.88 | 38.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 11 | 11 | $275.00 | $168.21 | 61.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $975.00 | $120.00 | 12.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 11 | 11 | $0.11 | $0.11 | 100.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 127 | 163 | $28,525 | $6,549 | 23.0% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2022 | 33 | 36 | $6,090 | $4,946 | 81.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 58 | 67 | $16,750 | $2,205 | 13.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 41 | 41 | $8,200 | $2,110 | 25.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 26 | 27 | $2,700 | $1,118 | 41.4% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 15 | 16 | $1,200 | $812.72 | 67.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 15 | 15 | $1,125 | $520.46 | 46.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 26 | 30 | $750.00 | $278.42 | 37.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 21 | 22 | $1,650 | $211.52 | 12.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 121 | 150 | $26,250 | $5,828 | 22.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 65 | $16,250 | $3,675 | 22.6% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 28 | 30 | $2,250 | $1,539 | 68.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 25 | 28 | $2,800 | $672.28 | 24.0% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 15 | 16 | $400.00 | $145.65 | 36.4% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 12 | 12 | $900.00 | $126.60 | 14.1% |
About Anthony Ramicone, PA-C
Anthony Ramicone, PA-C is a Physician Assistant healthcare provider based in Pawtucket, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/21/2017. The National Provider Identifier (NPI) number assigned to this provider is 1730690488.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Anthony Ramicone, PA-C has received a total of $1,210 in payments from pharmaceutical and medical device companies, with $374.22 received in 2024. These payments were reported across 60 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,105).
As a Medicare-enrolled provider, Ramicone has provided services to 918 Medicare beneficiaries, totaling 1,060 services with total Medicare billing of $42,260. Data is available for 3 years (2021–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Pawtucket, RI
- Active Since 10/21/2017
- Last Updated 11/14/2025
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1730690488
Products in Payments
- UBRELVY (Drug) $135.89
- XIFAXAN (Drug) $105.72
- FARXIGA (Drug) $90.08
- ELIQUIS (Drug) $71.02
- QULIPTA (Drug) $57.83
- REXULTI (Drug) $57.39
- TRULICITY (Drug) $52.51
- ONPATTRO (Drug) $51.38
- Wegovy (Drug) $42.17
- GEMTESA (Drug) $39.50
- TRELEGY ELLIPTA (Drug) $38.29
- Kerendia (Drug) $33.81
- YUPELRI (Drug) $33.31
- BREZTRI (Drug) $31.99
- AIRSUPRA (Drug) $27.39
- Tlando (Drug) $27.14
- OFEV (Drug) $23.60
- Korlym (Drug) $23.38
- SHINGRIX (Biological) $22.87
- PREVNAR 20 (Biological) $19.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Pawtucket
Kathryn Wisnewski, Pa, PA
Physician Assistant — Payments: $8,813
Physician Assistant $8,813
Mr. Derrick Robinson, Physician Assistant, PHYSICIAN ASSISTANT
Physician Assistant — Payments: $1,048
Physician Assistant $1,048
Pamela Bagdasian, Pa-C, PA-C
Physician Assistant — Payments: $664.25
Physician Assistant $664.25
Jordan Jutras, Pa-C, PA-C
Physician Assistant — Payments: $529.43
Physician Assistant $529.43
Mr. Benjamin Javery, Pa-C, PA-C
Physician Assistant — Payments: $118.36
Physician Assistant $118.36
Anthony Mattiello, Pa, PA
Physician Assistant — Payments: $88.65
Physician Assistant $88.65